genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Supplement
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
BioPerspectives
Subscribe
Create a Free Account
Log In
Get the GEN Mobile App
Get GEN Magazine
Get GEN eNewsletters
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
News
Alexion Inks Collaborations Totaling $1.3B+ with Affibody, Zealand
News
Pfizer Gains Option to Buy Rare Disease Gene Therapy Developer Vivet…
News
Autistic Symptoms Can Be Suppressed by Inhibiting Specific Enzyme
News
Parkinson’s Disease Odor Characterized with the Help of Human “Super Smeller”
News
Epigenetic Marks on Sperm Chromosomes Impact Gene Expression in Offspring
Insights
Commentary
Limitations in Single-Cell Analysis Must Be Addressed with Innovation
Cannabinoids
Liquid Gold: Engineers Strike Oil Making Customized Extractors for Cannabis
Bioprocessing
Addressing Challenges Posed by the Adoption of Single-Use Systems
Insights
Top 15 Best-Selling Drugs of 2018
Insights
Phage Therapy: Turning the Tables on Bacteria
A-Lists
Insights
Top 15 Best-Selling Drugs of 2018
March 2019 Vol. 39 No. 3
Top 10 Immuno-Oncology Startups
March 2019 Vol. 39 No. 3
Unlucky 13: Top Clinical Trial Failures of 2018
February 2019 Vol. 39 No. 2
10 Takeover Targets to Watch in 2019
Insights
Top 10 Global Biopharma IPOs of 2018
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
News
Alexion Inks Collaborations Totaling $1.3B+ with Affibody, Zealand
News
Pfizer Gains Option to Buy Rare Disease Gene Therapy Developer Vivet…
News
Parkinson’s Disease Odor Characterized with the Help of Human “Super Smeller”
News
Epigenetic Marks on Sperm Chromosomes Impact Gene Expression in Offspring
Magazine
All
Supplement
Insights
Phage Therapy: Turning the Tables on Bacteria
March 2019 Vol. 39 No. 3
Keeping Up with Bioprocess Changes
March 2019 Vol. 39 No. 3
Circulating Tumor Cells and the Liquid Biopsy
Insights
Novel Oncology Drug Discovery Strategies
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
BioPerspectives
Posters
Multiplexed Target Enrichment and High-Resolution NGS Analysis of On- and…
Webinars
Fibro-Inflammatory Disease Sees Relief in IL-11 mAb Development
eBooks
End Uncertainty: Break Through the Roadblocks to Monoclonal Antibody (mAb) Characterization
GENcast
GENcast: Explore, Learn, and Collaborate on Cell & Gene Therapy Manufacturing…
Subscribe
Create a Free Account
Log In
Get the GEN Mobile App
Get GEN Magazine
Get GEN eNewsletters
Search
Home
Companies
Merck & Co
Merck & Co
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Merck & Co
Merck, King’s Launch $344M+ Chronic Pain Drug Collaboration
Merck & Co
Merck to Acquire Immune Design for $300M, Boosting Immunotherapy Vaccine Pipeline
Merck & Co
Merck & Co. Partners with Sutro on Cytokine Derivatives for Cancer, Autoimmune Disorders
Merck & Co
Merck Invests $125M in Moderna in Expanded mRNA Cancer Vaccine Partnership
Merck & Co
Incyte, Merck & Co. Halt Phase III Trial After Epacadostat/Keytruda Combination Fails in Melanoma
Merck & Co
Merck & Co., Eisai Launch Up-to-$5.76B Cancer Partnership
Merck & Co
Merck to Acquire Oncolytic Immunotherapy Developer Viralytics for $394M
Merck & Co
Moderna Raises $500M Financing for mRNA R&D, Manufacturing
Merck & Co
Menlo Therapeutics Files for Up-to-$97.75M IPO
Merck & Co
Merck to Acquire Rigontec, Expanding Cancer Immunotherapy Franchise
Merck & Co
AstraZeneca, Merck Seal Cancer Drug Development Deal Worth Up to $8.5B
Merck & Co
Merck, Samsung Bioepis Launch Remicade Biosimilar in U.S.
Merck & Co
Merck Wins Tentative FDA Approval for Lusduna
Merck & Co
After Deaths, FDA Places Clinical Holds on Keytruda Combo Trials
Merck & Co
PD-L2 Helps Predict Immunotherapy Responsiveness for Head and Neck Cancer
Load more
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
